+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Trends and perspectives of drug development for hormone replacement in women and men

Trends and perspectives of drug development for hormone replacement in women and men

Molecular & Cellular Endocrinology 164(1-2): 254, June 20

(PDF 0-2 workdays service: $29.90)

Accession: 035985110

Download citation: RISBibTeXText

Related references

Hormone replacement therapy in endometrial cancer survivors: new perspectives after the heart and estrogen progestin replacement study and the women's health initiative. Journal of Lower Genital Tract Disease 10(2): 92-101, 2006

Perspectives on the women's health initiative trial of hormone replacement therapy. Obstetrics and Gynecology 101(4): 811;author Reply 812-3, 2003

Perspectives on the Women's Health Initiative trial of hormone replacement therapy. Obstetrics & Gynecology 100(6): 1344-1353, December, 2002

Role of hormone replacement in the management of osteoporosis in haemodialysed women: perspectives for the future. Nephrology, Dialysis, Transplantation 15 Suppl 5: 36-37, 2000

Skin aging and sex hormones in women -- clinical perspectives for intervention by hormone replacement therapy. Experimental Dermatology 13 Suppl 4: 36-40, 2004

Perspectives on hormone replacement therapy: the Women's Health Initiative and new observational studies sampling the overall population. Fertility and Sterility 90(2): 258-264, 2008

Hormone replacement Up-to-date. Menopause in women and hormone replacement therapy (HRT). Indications for HRT in postmenopausal women. Clinical Calcium 17(9): 1315-1324, 2007

Trends and perspectives in drug research and development. Fortschritte der Medizin 96(12): 615-6, 642, 1978

Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women. Journal of Cardiovascular Medicine 10(1): 85-92, 2009

Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. Journal of Epidemiology and Community Health 59(9): 740-748, 2005

The place of simultaneous pharmacokinetic pharmacodynamic modeling in new drug development: trends and perspectives. Fundamental & Clinical Pharmacology 4 Suppl 2: 103s-115s, 1990

Changes in bone density in women starting hormone replacement therapy compared with those in women already established on hormone replacement therapy. Osteoporosis International 5(5): 344-348, 1995

Drug-mediated correction of negative phlebotropic effects of hormone replacement therapy in women. Angiologiia i Sosudistaia Khirurgiia 15(3): 87-91, 2010

Hormone replacement Up-to-date. Practical tips for hormone replacement therapy in women. Clinical Calcium 17(9): 1407-1413, 2007

Endometrial safety during administration of the combined estrogen-progestogen hormone replacement drug Klimonorm in perimenopausal women. Drugs of Today 37(Suppl C): 31-35, June, 2001